Jun Jia Selected Research

Jun Jia Research Topics

Disease

41	Neoplasms (Cancer) 06/2022 - 11/2005
16	Breast Neoplasms (Breast Cancer) 01/2020 - 10/2008
13	Parkinson Disease (Parkinson's Disease) 01/2022 - 09/2009
10	Glioma (Gliomas) 01/2022 - 06/2018
8	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 11/2005
8	Esophageal Squamous Cell Carcinoma 01/2022 - 04/2016
7	Neoplasm Metastasis (Metastasis) 01/2020 - 05/2011
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2021 - 08/2012
6	Hemangioma (Angioma) 12/2015 - 01/2007
5	Carcinogenesis 01/2021 - 06/2013
5	Wounds and Injuries (Trauma) 02/2016 - 11/2004
4	Inflammation (Inflammations) 01/2022 - 10/2012
4	Infections 09/2019 - 05/2015
4	Squamous Cell Carcinoma of Head and Neck 01/2019 - 05/2011
4	Hypoxia (Hypoxemia) 06/2013 - 01/2010
4	Adenoid Cystic Carcinoma (Cylindroma) 02/2013 - 08/2010
3	Lung Neoplasms (Lung Cancer) 01/2022 - 08/2012
3	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 01/2019
3	Disease Progression 12/2020 - 09/2019
3	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 10/2016
3	Pain (Aches) 05/2016 - 11/2013
3	Burns 02/2016 - 12/2014
3	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2015 - 09/2009
2	Cataract (Cataracts) 01/2022 - 01/2021
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 11/2013
2	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2020
2	Glioblastoma (Glioblastoma Multiforme) 12/2021 - 04/2015
2	Nasopharyngeal Carcinoma 10/2021 - 10/2016
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 12/2019
2	Diarrhea 09/2019 - 05/2015
2	Diabetic Retinopathy (Retinopathy, Diabetic) 06/2019 - 10/2017
2	Lymphatic Metastasis 01/2019 - 01/2017
2	Heart Failure 04/2017 - 01/2014
2	Neutropenia 10/2016 - 05/2015
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 04/2016 - 01/2016
2	Illusions (Auditory Illusions) 02/2014 - 07/2011
2	Mouth Neoplasms (Oral Cancer) 01/2013 - 05/2011
2	Fibrosis (Cirrhosis) 10/2012 - 02/2009

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 02/2021 - 07/2008
7	Biomarkers (Surrogate Marker)IBA 06/2022 - 08/2012
7	Cisplatin (Platino)FDA LinkGeneric 10/2021 - 01/2016
6	Pharmaceutical PreparationsIBA 01/2022 - 04/2017
6	Messenger RNA (mRNA)IBA 01/2021 - 07/2008
5	HydrogelsIBA 07/2021 - 01/2020
5	Biological ProductsIBA 06/2021 - 07/2002
5	Long Noncoding RNAIBA 01/2021 - 01/2018
4	Fluorouracil (Carac)FDA LinkGeneric 10/2021 - 10/2016
4	EnzymesIBA 02/2021 - 01/2020
4	Temozolomide (Temodar)FDA LinkGeneric 02/2021 - 01/2020
4	RNA (Ribonucleic Acid)IBA 02/2021 - 11/2005
4	ErbB Receptors (EGF Receptor)IBA 12/2020 - 01/2019
4	Paclitaxel (Taxol)FDA LinkGeneric 11/2020 - 01/2011
3	Immune Checkpoint InhibitorsIBA 06/2022 - 12/2019
3	taxaneIBA 01/2022 - 05/2015
3	Matrix Metalloproteinases (MMPs)IBA 07/2021 - 01/2020
3	Irinotecan (Camptosar)FDA LinkGeneric 02/2021 - 10/2016
3	MicroRNAs (MicroRNA)IBA 01/2021 - 05/2011
3	Gefitinib (Iressa)FDA Link 01/2020 - 01/2012
3	PlatinumIBA 01/2020 - 01/2016
3	Adenosine Triphosphate (ATP)IBA 01/2020 - 10/2008
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 04/2013
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 01/2016
3	RNA Splicing FactorsIBA 01/2019 - 09/2015
3	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 10/2013 - 01/2011
3	TOR Serine-Threonine KinasesIBA 06/2013 - 08/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013 - 01/2010
3	Docetaxel (Taxotere)FDA Link 07/2012 - 02/2011
3	Oxygen (Dioxygen)IBA 02/2012 - 08/2004
2	Gemcitabine FDA Link 10/2021 - 10/2016
2	Tyrosine Kinase InhibitorsIBA 05/2021 - 01/2020
2	apatinibIBA 02/2021 - 01/2020
2	CopperIBA 01/2021 - 01/2019
2	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 11/2020 - 07/2008
2	MethyltransferasesIBA 09/2020 - 01/2011
2	Oxidopamine (6 Hydroxydopamine)IBA 09/2020 - 01/2018
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2020 - 01/2017
2	Circular RNAIBA 01/2020 - 06/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 01/2011
2	Angiopep-2IBA 01/2020 - 09/2019
2	Small Interfering RNA (siRNA)IBA 01/2020 - 01/2016
2	AntigensIBA 12/2019 - 04/2011
2	Tumor Biomarkers (Tumor Markers)IBA 12/2019 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 09/2019 - 12/2015
2	nimotuzumabIBA 01/2019 - 04/2016
2	pro-brain natriuretic peptide (1-76)IBA 04/2017 - 01/2014
2	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2017 - 01/2014
2	ParaffinIBA 03/2016 - 10/2008
2	Therapeutic UsesIBA 05/2015 - 01/2013
2	AnthracyclinesIBA 05/2015 - 01/2011
2	CytokinesIBA 10/2013 - 02/2013

Therapy/Procedure

22	Therapeutics 12/2021 - 06/2005
17	Drug Therapy (Chemotherapy) 01/2022 - 01/2011
8	Immunotherapy 06/2022 - 11/2005
8	Electroacupuncture 09/2020 - 01/2012
5	Injections 07/2021 - 05/2016
3	Radiotherapy 09/2019 - 03/2015
3	Skin Transplantation (Skin Grafting) 02/2016 - 12/2014
2	Phacoemulsification 01/2022 - 01/2021
2	Deep Brain Stimulation 01/2019 - 01/2018
2	Sclerotherapy 11/2013 - 10/2012